These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 15883104)

  • 1. Guidelines for hormone treatment of women in the menopausal transition and beyond.
    Naftolin F; Schneider HP; Sturdee DW;
    Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104
    [No Abstract]   [Full Text] [Related]  

  • 2. Progestins and recurrence in breast cancer survivors.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2005 Apr; 97(7):471-2. PubMed ID: 15812065
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of menopausal hormones in the United States, 1992 through June, 2003.
    Wysowski DK; Governale LA
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):171-6. PubMed ID: 15386701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. United States regulatory considerations for intrauterine progestins for hormone replacement therapy.
    Rarick L
    Contraception; 2007 Jun; 75(6 Suppl):S140-3. PubMed ID: 17531606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.
    Archer DF
    Semin Reprod Med; 2005 May; 23(2):188-95. PubMed ID: 15852205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 8. [Estrogens following menopause. Methods of hormone replacement].
    Robyn C
    Rev Med Brux; 1995; 16(4):291-4. PubMed ID: 7481245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global consensus statement on menopausal hormone therapy.
    de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
    Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
    Stefanick ML
    Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on continuous estrogen-progestin replacement therapy.
    Rosenfeld JA
    Am Fam Physician; 1994 Nov; 50(7):1519-23, 1527-8. PubMed ID: 7976988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.
    Seifert-Klauss V; Kingwell E; Hitchcock CL; Kalyan S; Prior JC
    Menopause; 2008; 15(1):203; author reply 203-4. PubMed ID: 18182940
    [No Abstract]   [Full Text] [Related]  

  • 13. Menopausal hormone replacement therapy in dermatology.
    Danby FW
    JAMA Dermatol; 2014 Dec; 150(12):1261-2. PubMed ID: 25250584
    [No Abstract]   [Full Text] [Related]  

  • 14. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
    Twombly R
    J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
    [No Abstract]   [Full Text] [Related]  

  • 15. Menopausal hormones and risk of ovarian cancer.
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
    Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational studies and clinical trials of menopausal hormone therapy: can they both be right?
    Allison MA; Manson JE
    Menopause; 2006; 13(1):1-3. PubMed ID: 16607089
    [No Abstract]   [Full Text] [Related]  

  • 17. Plausible--yes. But ..
    Fenton A; Panay N
    Climacteric; 2009 Dec; 12(6):461-2. PubMed ID: 19905898
    [No Abstract]   [Full Text] [Related]  

  • 18. Estrogen with and without progestin: benefits and risks of short-term use.
    LaCroix AZ
    Am J Med; 2005 Dec; 118 Suppl 12B():79-87. PubMed ID: 16414331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical practice. Management of menopausal symptoms.
    Grady D
    N Engl J Med; 2006 Nov; 355(22):2338-47. PubMed ID: 17135587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.